Camp4 Therapeutics (CAMP) EBT Margin (2023 - 2026)
Camp4 Therapeutics (CAMP) reported EBT Margin of 944.13% for Q1 2026, up 64655.0% on a YoY basis from N/an in Q1 2025, and up 74.61% sequentially from 3718.97% in Q4 2025.
Camp4 Therapeutics (CAMP) EBT Margin (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of EBT Margin data on file, last reported at 944.13% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 64655.0% year-over-year to 944.13%; the trailing twelve-month figure through Mar 2026 stood at 1509.71% (up 278135.0% YoY), and the FY2025 full-year result was 3616.95%, up 1427860.0% from the prior year.
- EBT Margin improved to 944.13% in Q1 2026, from 3718.97% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 944.13% in Q1 2026 to a low of 3718.97% in Q4 2025.
- A 4-year average of 2158.34% and a median of 1774.09% in 2025 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin sank 152709 bps in 2025 and jumped 64655 bps in 2026, its largest moves.
- Tracing CAMP's EBT Margin over 4 years: stood at 3544.0% in 2023, then jumped by 38 bps to 2191.87% in 2024, then tumbled by 70 bps to 3718.97% in 2025, then jumped by 75 bps to 944.13% in 2026.
- Business Quant data shows CAMP's EBT Margin at 944.13% in Q1 2026, 3718.97% in Q4 2025, and 1774.09% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | -944.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -944.13% |
| Dec 31, 2025 | -3,718.97% |
| Sep 30, 2025 | -1,774.09% |
| Jun 30, 2025 | -1,344.62% |
| Mar 31, 2025 | -1,590.68% |
| Dec 31, 2024 | -2,191.87% |
| Sep 30, 2023 | -3,544.00% |